January 26, 2010; 74 (4) Special Article
Practice Parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review)
Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
M. R. Delgado, D. Hirtz, M. Aisen, S. Ashwal, D. L. Fehlings, J. McLaughlin, L. A. Morrison, M. W. Shrader, A. Tilton, J. Vargus-Adams
First published January 25, 2010, DOI: https://doi.org/10.1212/WNL.0b013e3181cbcd2f
M. R. Delgado
D. Hirtz
M. Aisen
S. Ashwal
D. L. Fehlings
J. McLaughlin
L. A. Morrison
M. W. Shrader
A. Tilton
Practice Parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review)
Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
M. R. Delgado, D. Hirtz, M. Aisen, S. Ashwal, D. L. Fehlings, J. McLaughlin, L. A. Morrison, M. W. Shrader, A. Tilton, J. Vargus-Adams
Neurology Jan 2010, 74 (4) 336-343; DOI: 10.1212/WNL.0b013e3181cbcd2f
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 74 no. 4 336-343
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published January 25, 2010.
Copyright & Usage:
© 2010
Author Disclosures
- M. R. Delgado, MD, FRCPC, FAAN,
- D. Hirtz, MD, FAAN,
- M. Aisen, MD, FAAN,
- S. Ashwal, MD, FAAN,
- D. L. Fehlings, MD, MSc, FRCPC,
- J. McLaughlin, MD,
- L. A. Morrison, MD,
- M. W. Shrader, MD,
- A. Tilton, MD, FAAN and
- J. Vargus-Adams, MD, MS
- M. R. Delgado, MD, FRCPC, FAAN,
- D. Hirtz, MD, FAAN,
- M. Aisen, MD, FAAN,
- S. Ashwal, MD, FAAN,
- D. L. Fehlings, MD, MSc, FRCPC,
- J. McLaughlin, MD,
- L. A. Morrison, MD,
- M. W. Shrader, MD,
- A. Tilton, MD, FAAN and
- J. Vargus-Adams, MD, MS
- From the University of Texas Southwestern Medical Center (M.R.D.), Dallas; National Institute of Neurological Disorders and Stroke (D.H.), Bethesda, MD; United Cerebral Palsy Research Foundation (M.A.); Loma Linda University (S.A.), Loma Linda, CA; Bloorview Kids Rehab (D.L.F.), Toronto, Canada; University of Washington (J.M.), Seattle; University of New Mexico (L.A.M.), Albuquerque; The Core Institute (M.W.S.), Sun City West, AZ; Louisiana State University (A.T.), New Orleans; and Cincinnati Children's Hospital (J.V.-A.), Cincinnati, OH.
- Address correspondence and reprint requests to American Academy of Neurology, 1080 Montreal Avenue, St. Paul, MN 55116 guidelines{at}aan.com
Article usage
Cited By...
Letters: Rapid online correspondence
- Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy
- Mary Anne Whelan, PhD, MD, Cerebral Palsy of Upstate New York, 122 Sugar Hill Rd., Cooperstown, NY 13326mawhelan@hughes.net
Submitted May 17, 2010 - Reply from the author
- Mauricio R. Delgado, MD, FRCPC, FAAN, University of Texas Southwestern Medical Center, Harry Hines Blvd, Dallas, TexasGuidelines@aan.com
Submitted May 17, 2010
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Alert Me
Recommended articles
-
Articles
Botulinum toxin type A in the treatment of upper extremity spasticityA randomized, double‐blind, placebo‐controlled trialD. M. Simpson, D. N. Alexander, C. F. O'Brien et al.Neurology, May 01, 1996 -
Views & Reviews
Oral antispastic drugs in nonprogressive neurologic diseasesA systematic reviewE. Montané, A. Vallano, J. R. Laporte et al.Neurology, October 25, 2004 -
Article
Assessing and treating functional impairment in poststroke spasticityKatharina S. Sunnerhagen, John Olver, Gerard E. Francisco et al.Neurology, January 14, 2013 -
ARTICLES
Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injuryAn open-labeled trialStuart A. Yablon, Benjamin T. Agana, Cindy B. Ivanhoe et al.Neurology, October 01, 1996